Long-term results of treatment for recurrent supercifial bladder carcinoma with “Imuron” BCG vaccine
https://doi.org/10.17650/1726-9776-2006-2-2-40-43
Abstract
Intravesical immunotherapy with the BCG vaccine «Imuron» along with courses of maintenance therapy has been performed in 25 patients. During a more than 10-year follow-up, there are 20 (80%) survivors; of them 15 (75%) patients have no recurrences. The used treatment regimen is effective and allows a long monitoring of the disease with the good quality of life. The occurrence of recurrences in 5 (25%) patients in the late period of the follow-up (after 8-13.5 years) leads to the conclusion that patients should be long followed up by an oncourologist and undergo cytoscopic studies with photodynamic diagnosis.
About the Authors
K. N. Safiullin
Medical Radiology Research Center, Russian Academy of Medical Sciences
Russian Federation
Obninsk
Russian Federation
Obninsk
O. B. Karyakin
Medical Radiology Research Center, Russian Academy of Medical Sciences
Russian Federation
Obninsk
Russian Federation
Obninsk
References
1. Давыдов М.И., Аксель Е.М. Злокачественные новообразования в России и странах СНГ в 2003 г. М. 2005.
2. Карякин О.Б. Факторы прогноза у больных поверхностным раком мочевого пузыря. Актуальные вопросы лечения онкоурологических заболеваний. Обнинск 1997.
3. Morales A., Eidinger D., Bruce A.W. Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder cancer. J Urol (Baltimore) 1976;116:180—3.
4. Фигурин К.М. Клиническая онкоурология. М. 2003;271–93.
5. Lamm D.L. Preventing progression and improving survival with BCG maintenance. Eur Urol 2000;37 (Suppl 1): 9—15.
6. Hanna M.G., De Iager R., Guinan P. et al. Bacillus Calmette-Guerin (BCG) vaccine for Tuberculosis: Antitumor effect in Experimental Animals and Humans. Vaccine Research 1992;1(2):69—91.
7. Mitjes J.A.,Van der Meijden A.P. et al. A randomized prospective staid comparing intravesical instillations of Mitomycin – C, BCG TICE and BCG RIVM in pTa-pT1 tumors and primary carcinoma in situ of the urinary bladder. Eur J Cancer 1993;12:1672.
Review
For citations:
Safiullin K.N., Karyakin O.B. Long-term results of treatment for recurrent supercifial bladder carcinoma with “Imuron” BCG vaccine. Cancer Urology. 2006;2(2):40-43. (In Russ.) https://doi.org/10.17650/1726-9776-2006-2-2-40-43
Views:
327
Email this article 